Tango Therapeutics (TNGX) Prepaid Assets (2020 - 2026)
Tango Therapeutics (TNGX) recorded quarterly Prepaid Assets of $12.5 million in Q1 2026, up 22.55% quarter-over-quarter from $10.2 million in Q4 2025, and up 60.56% on a YoY basis from $7.8 million in Q1 2025.
Tango Therapeutics (TNGX) Prepaid Assets (2020 - 2026) Analysis & Trends
Tango Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $12.5 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 60.56% year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (up 60.56% YoY), while the FY2025 annual figure was $10.2 million, up 20.94% from the prior year.
- Prepaid Assets was $12.5 million for Q1 2026 at Tango Therapeutics, up from $10.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $17.2 million in Q2 2022 to a low of $5.8 million in Q3 2022.
- Historically, Prepaid Assets has averaged $9.2 million across 5 years, with a median of $8.8 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 11238.91% in 2022, then sank 47.35% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $6.6 million in 2022, then jumped by 33.86% to $8.8 million in 2023, then declined by 4.22% to $8.4 million in 2024, then grew by 20.94% to $10.2 million in 2025, then rose by 22.55% to $12.5 million in 2026.
- The last three Prepaid Assets figures came in at $12.5 million (Q1 2026), $10.2 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tango Therapeutics | 4.05 Bn | 3.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.49 Mn |
| Dec 31, 2025 | 10.19 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 8.89 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 8.43 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 8.80 Mn |
| Sep 30, 2023 | 10.16 Mn |
| Jun 30, 2023 | 9.04 Mn |
| Mar 31, 2023 | 9.36 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | 5.81 Mn |
| Jun 30, 2022 | 17.16 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.53 Mn |
| Jun 30, 2021 | 151,355.00 |